Ausbil Investment Management Ltd Buys Shares of 964 Chemed Co. (NYSE:CHE)

Ausbil Investment Management Ltd acquired a new stake in Chemed Co. (NYSE:CHE) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 964 shares of the company’s stock, valued at approximately $579,000.

A number of other institutional investors have also made changes to their positions in CHE. GAMMA Investing LLC increased its position in shares of Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after purchasing an additional 22 shares during the period. American National Bank & Trust bought a new position in shares of Chemed in the third quarter worth about $61,000. EntryPoint Capital LLC increased its stake in shares of Chemed by 14.0% in the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after buying an additional 18 shares during the period. Mather Group LLC. raised its position in shares of Chemed by 60.5% during the second quarter. Mather Group LLC. now owns 183 shares of the company’s stock worth $99,000 after acquiring an additional 69 shares during the last quarter. Finally, Quarry LP boosted its holdings in Chemed by 721.7% in the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after acquiring an additional 166 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

Chemed Stock Up 0.1 %

NYSE CHE traded up $0.57 on Thursday, reaching $593.72. The company had a trading volume of 12,152 shares, compared to its average volume of 83,245. Chemed Co. has a 52 week low of $502.64 and a 52 week high of $654.62. The stock has a market cap of $8.99 billion, a price-to-earnings ratio of 31.92, a PEG ratio of 2.44 and a beta of 0.44. The stock’s 50 day moving average is $585.24 and its 200-day moving average is $570.10.

Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing the consensus estimate of $5.59 by ($0.12). The company had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the company earned $4.71 EPS. As a group, analysts forecast that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were issued a dividend of $0.50 per share. This is a boost from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date was Monday, August 12th. This represents a $2.00 annualized dividend and a yield of 0.34%. Chemed’s dividend payout ratio is presently 10.76%.

Insiders Place Their Bets

In other news, Director Andrea R. Lindell sold 831 shares of the stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $571.51, for a total value of $474,924.81. Following the completion of the sale, the director now owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, Director Andrea R. Lindell sold 831 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $571.51, for a total value of $474,924.81. Following the completion of the sale, the director now directly owns 5,725 shares of the company’s stock, valued at $3,271,894.75. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Nicholas Michael Westfall sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the transaction, the executive vice president now directly owns 5,990 shares in the company, valued at $3,363,864.20. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 9,144 shares of company stock valued at $5,264,839 in the last three months. 3.32% of the stock is currently owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.